Preferential allotment on share swap basis: continual disclosure of equity shares acquired
iSERA Lifesciences Ltd (formerly Covidh Technologies Ltd) has disclosed a preferential allotment of equity shares on a share swap basis.
- Allottee - Shubhangi Dhanraj Garad
- 27,55,000 equity shares, 4.95%
- Allottee - Sumeet Dhanraj Garad
- 11,92,000 equity shares, 4.06%
- Mode of Acquisition
- Acquisition – Preferential Allotment (Share Swap)
What was disclosed
iSERA Lifesciences Limited (formerly known as Covidh Technologies Limited) has informed the exchange of a continual disclosure under Regulation 7(2) read with Regulation 6(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015, consequent to a preferential allotment of equity shares on a share swap basis. The update sets out the allottees, the number of equity shares each acquired, and each holding as a percentage of paid-up share capital.
Allottees in the table
The larger entries listed are
- Shubhangi Dhanraj Garad: 27,55,000 equity shares, 4.95% of paid-up share capital
- Sumeet Dhanraj Garad: 11,92,000 equity shares, 4.06% of paid-up share capital
- Ritu Dhanraj Garad: 7,46,000 equity shares, 2.25% of paid-up share capital
- The table also lists other allottees with smaller numbers of shares, and against every row the nature of transaction is shown as Preferential Allotment – Share Swap
What the enclosed Form C shows
The individual Form C disclosures describe the allottees as belonging to the Promoter Group, with the securities held prior to acquisition shown as Equity Shares at 0.00%.
- The mode of acquisition is stated as Acquisition – Preferential Allotment (Share Swap), and the exchange on which the trade was executed is marked N.A.
- Babasaheb Mahadeo Bhosale: value shown for the shares acquired 38,56,000
- Madan Manohar Ballal: value shown for the shares acquired 48,20,000
- The update notes that the value of transaction excludes taxes, brokerage and any other charges
How to read this
- This is a change-in-shareholding disclosure, not a business or financial results update.
- The % of Paid-up Share Capital column shows how large each allottee's shares are in relation to the company's paid-up capital, which helps a reader judge the size of each allotment.
- The allotment is described as a share swap, and the exchange column is marked N.A., so these were not exchange-traded purchases.
- The update states that the individual Form C disclosures of each allottee are enclosed as separate annexures.
Also from iSERA Lifesciences
iSERA Lifesciences Ltd promoter buys 2.01% stake, holding rises to 4.86%
7 Oct 2026
iSERA Lifesciences Ltd promoter buys 1.86% stake, holding rises to 6.39%
7 Oct 2026
iSERA Lifesciences Ltd promoter buys 4.06% stake, holding rises to 5.25%
6 Oct 2026
More numbers
- Shubhangi Dhanraj Garad - equity shares acquired27,55,000
- Shubhangi Dhanraj Garad - % of paid-up share capital4.95%
- Sumeet Dhanraj Garad - equity shares acquired11,92,000
- Sumeet Dhanraj Garad - % of paid-up share capital4.06%
- Ritu Dhanraj Garad - equity shares acquired7,46,000
- Ritu Dhanraj Garad - % of paid-up share capital2.25%
- Babasaheb Mahadeo Bhosale - value of shares acquired38,56,000
- Madan Manohar Ballal - value of shares acquired48,20,000
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.